vs
FrontView REIT, Inc.（FVR）与Immunovant, Inc.（IMVT）财务数据对比。点击上方公司名可切换其他公司
FrontView REIT, Inc.的季度营收约是Immunovant, Inc.的2.0倍（$16.5M vs $8.4M），FrontView REIT, Inc.净利率更高（-24.9% vs -899.0%，领先874.1%）
Immunovant是一家临床阶段生物制药企业，专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法，其核心在研候选产品覆盖多种自身免疫适应症，面向全球医疗市场布局研发管线。
FVR vs IMVT — 直观对比
营收规模更大
FVR
是对方的2.0倍
$8.4M
净利率更高
FVR
高出874.1%
-899.0%
损益表 — Q4 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $16.5M | $8.4M |
| 净利润 | $-4.1M | $-75.3M |
| 毛利率 | — | — |
| 营业利润率 | — | -896.2% |
| 净利率 | -24.9% | -899.0% |
| 营收同比 | — | 140.7% |
| 净利润同比 | — | -26.7% |
| 每股收益（稀释后） | $-0.19 | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVRIMVT
| Q4 25 | $16.5M | — | ||
| Q3 25 | $16.8M | — | ||
| Q2 25 | $17.6M | — | ||
| Q1 25 | $16.2M | — | ||
| Q3 24 | $14.5M | — | ||
| Q1 24 | — | $8.4M | ||
| Q4 23 | — | $8.9M | ||
| Q3 23 | — | $3.6M |
净利润FVRIMVT
| Q4 25 | $-4.1M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $-2.9M | — | ||
| Q1 25 | $-833.0K | — | ||
| Q3 24 | $-2.4M | — | ||
| Q1 24 | — | $-75.3M | ||
| Q4 23 | — | $-51.4M | ||
| Q3 23 | — | $-58.7M |
营业利润率FVRIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | -896.2% | ||
| Q4 23 | — | -576.8% | ||
| Q3 23 | — | -1629.6% |
净利率FVRIMVT
| Q4 25 | -24.9% | — | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | -16.5% | — | ||
| Q1 25 | -5.1% | — | ||
| Q3 24 | -16.7% | — | ||
| Q1 24 | — | -899.0% | ||
| Q4 23 | — | -575.6% | ||
| Q3 23 | — | -1642.3% |
每股收益（稀释后）FVRIMVT
| Q4 25 | $-0.19 | — | ||
| Q3 25 | $0.19 | — | ||
| Q2 25 | $-0.16 | — | ||
| Q1 25 | $-0.06 | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | $-0.50 | ||
| Q4 23 | — | $-0.36 | ||
| Q3 23 | — | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.5M | $635.4M |
| 总债务越低越好 | $314.3M | — |
| 股东权益账面价值 | $391.2M | $617.8M |
| 总资产 | $854.4M | $666.4M |
| 负债/权益比越低杠杆越低 | 0.80× | — |
8季度趋势，按日历期对齐
现金及短期投资FVRIMVT
| Q4 25 | $13.5M | — | ||
| Q3 25 | $19.6M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $3.3M | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | $635.4M | ||
| Q4 23 | — | $690.9M | ||
| Q3 23 | — | $269.9M |
总债务FVRIMVT
| Q4 25 | $314.3M | — | ||
| Q3 25 | $307.1M | — | ||
| Q2 25 | $316.9M | — | ||
| Q1 25 | $310.2M | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
股东权益FVRIMVT
| Q4 25 | $391.2M | — | ||
| Q3 25 | $385.2M | — | ||
| Q2 25 | $369.9M | — | ||
| Q1 25 | $324.7M | — | ||
| Q3 24 | $1.0K | — | ||
| Q1 24 | — | $617.8M | ||
| Q4 23 | — | $679.3M | ||
| Q3 23 | — | $251.8M |
总资产FVRIMVT
| Q4 25 | $854.4M | — | ||
| Q3 25 | $846.8M | — | ||
| Q2 25 | $856.5M | — | ||
| Q1 25 | $860.8M | — | ||
| Q3 24 | $1.0K | — | ||
| Q1 24 | — | $666.4M | ||
| Q4 23 | — | $711.4M | ||
| Q3 23 | — | $292.1M |
负债/权益比FVRIMVT
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.96× | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $42.1M | $-59.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-59.8M |
| 自由现金流率自由现金流/营收 | — | -714.4% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-214.6M |
8季度趋势，按日历期对齐
经营现金流FVRIMVT
| Q4 25 | $42.1M | — | ||
| Q3 25 | $8.3M | — | ||
| Q2 25 | $9.3M | — | ||
| Q1 25 | $8.1M | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | $-59.7M | ||
| Q4 23 | — | $-47.1M | ||
| Q3 23 | — | $-60.1M |
自由现金流FVRIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | $-59.8M | ||
| Q4 23 | — | $-47.2M | ||
| Q3 23 | — | $-60.1M |
自由现金流率FVRIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | -714.4% | ||
| Q4 23 | — | -528.7% | ||
| Q3 23 | — | -1682.4% |
资本支出强度FVRIMVT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | 1.8% | ||
| Q4 23 | — | 1.5% | ||
| Q3 23 | — | 1.0% |
现金转化率FVRIMVT
| Q4 25 | — | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
